MX2011009212A - Lipoatrofia cosmetica medicinal. - Google Patents
Lipoatrofia cosmetica medicinal.Info
- Publication number
- MX2011009212A MX2011009212A MX2011009212A MX2011009212A MX2011009212A MX 2011009212 A MX2011009212 A MX 2011009212A MX 2011009212 A MX2011009212 A MX 2011009212A MX 2011009212 A MX2011009212 A MX 2011009212A MX 2011009212 A MX2011009212 A MX 2011009212A
- Authority
- MX
- Mexico
- Prior art keywords
- lipoatrophy
- corticosteroids
- medicinal cosmetic
- cosmetic lipoatrophy
- injections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Las inyecciones locales de corticoesteroides, más específicamente, las inyecciones intralesionales de corticoesteroides y, de preferencia, de triamcinolona y sus derivados, son adecuadas para producir medicamentos que se van a inyectar en la grasa subcutánea a niveles profundos, para provocar lipoatrofia cosmética de los pequeños depósitos de grasa en la cara y el cuerpo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20906509P | 2009-03-02 | 2009-03-02 | |
PCT/BR2010/000059 WO2010099587A1 (en) | 2009-03-02 | 2010-03-02 | Medicinal cosmetic lipoatrophy |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011009212A true MX2011009212A (es) | 2011-12-06 |
MX337850B MX337850B (es) | 2016-03-23 |
Family
ID=42709157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011009212A MX337850B (es) | 2009-03-02 | 2010-03-02 | Lipoatrofia cosmetica medicinal. |
Country Status (11)
Country | Link |
---|---|
US (2) | US9220717B2 (es) |
EP (1) | EP2403502A4 (es) |
JP (1) | JP6006940B2 (es) |
KR (1) | KR20120104487A (es) |
CN (1) | CN102341109A (es) |
AU (1) | AU2010220830B2 (es) |
BR (1) | BRPI1007812B1 (es) |
CA (1) | CA2754008C (es) |
MX (1) | MX337850B (es) |
RU (1) | RU2530629C2 (es) |
WO (1) | WO2010099587A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2014103543A (ru) * | 2011-07-20 | 2015-08-27 | Аллерган, Инк. | Ботулотоксины для применения в способе лечения жировых отложений |
US10493024B2 (en) * | 2015-10-12 | 2019-12-03 | Hk Tumescent Pharma Corporation | Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity |
KR101972588B1 (ko) * | 2018-07-31 | 2019-04-26 | 정채홍 | 지방분해 및 지방제거 시술 전처리용 조성물 |
WO2020081590A1 (en) | 2018-10-16 | 2020-04-23 | Rotunda Adam M | Alcohol-based compositions and uses thereof |
EP3917507A4 (en) * | 2019-01-31 | 2022-11-09 | HK Pharma | TUMESCENCE INFILTRATION DRUG DELIVERY OF CANNABINOIDS |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US20040141925A1 (en) * | 1998-11-12 | 2004-07-22 | Elan Pharma International Ltd. | Novel triamcinolone compositions |
US7098189B2 (en) * | 2002-12-16 | 2006-08-29 | Kimberly-Clark Worldwide, Inc. | Wound and skin care compositions |
US20050143347A1 (en) * | 2003-12-22 | 2005-06-30 | Aventis Pharma Deutschland Gmbh | Medicinal lipolysis of accumulations of fat |
DE10361067A1 (de) * | 2003-12-22 | 2005-07-14 | Aventis Pharma Deutschland Gmbh | Medikamentöse Lipolyse von Fettansammlungen |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
EP2422789B1 (en) * | 2004-05-19 | 2017-11-22 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Injectable coposition comprising sodium deoxycholate |
EP1824463A1 (en) * | 2004-12-14 | 2007-08-29 | Menarini Ricerche S.p.A. | Pharmaceutical compositions for the treatment of cellulite |
US20060211665A1 (en) * | 2005-03-17 | 2006-09-21 | Ranawat Chitranjan S | Reduction of postoperative pain medication |
EP1888101B1 (en) * | 2005-06-06 | 2012-03-21 | Georgetown University | Compositions and methods for lipo modeling |
-
2010
- 2010-03-02 KR KR1020117022756A patent/KR20120104487A/ko active Search and Examination
- 2010-03-02 CA CA2754008A patent/CA2754008C/en active Active
- 2010-03-02 AU AU2010220830A patent/AU2010220830B2/en active Active
- 2010-03-02 BR BRPI1007812-6A patent/BRPI1007812B1/pt active IP Right Grant
- 2010-03-02 US US13/810,022 patent/US9220717B2/en active Active
- 2010-03-02 CN CN2010800103120A patent/CN102341109A/zh active Pending
- 2010-03-02 JP JP2011552282A patent/JP6006940B2/ja active Active
- 2010-03-02 RU RU2011139015/15A patent/RU2530629C2/ru active
- 2010-03-02 WO PCT/BR2010/000059 patent/WO2010099587A1/en active Application Filing
- 2010-03-02 MX MX2011009212A patent/MX337850B/es active IP Right Grant
- 2010-03-02 EP EP10748244A patent/EP2403502A4/en not_active Withdrawn
-
2014
- 2014-04-02 US US14/243,483 patent/US9408857B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2010099587A1 (en) | 2010-09-10 |
RU2011139015A (ru) | 2013-04-10 |
CA2754008A1 (en) | 2010-09-10 |
CA2754008C (en) | 2016-04-26 |
MX337850B (es) | 2016-03-23 |
AU2010220830B2 (en) | 2016-07-14 |
KR20120104487A (ko) | 2012-09-21 |
CN102341109A (zh) | 2012-02-01 |
EP2403502A4 (en) | 2012-11-07 |
RU2530629C2 (ru) | 2014-10-10 |
US9408857B2 (en) | 2016-08-09 |
EP2403502A1 (en) | 2012-01-11 |
US9220717B2 (en) | 2015-12-29 |
BRPI1007812B1 (pt) | 2017-09-26 |
US20140213562A1 (en) | 2014-07-31 |
JP2012519189A (ja) | 2012-08-23 |
US20130116223A1 (en) | 2013-05-09 |
BRPI1007812A2 (pt) | 2016-02-23 |
AU2010220830A1 (en) | 2011-10-13 |
JP6006940B2 (ja) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011007589A (es) | Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20. | |
WO2013122931A3 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
WO2009093104A3 (en) | Use of transesterified olive oil in the cosmetic field | |
MX355080B (es) | Mejora de la apariencia de la piel con aumento en la intensidad cromatica de la piel. | |
MX2011007536A (es) | Compuestos beta amino ester y usos de los mismos. | |
EP2295028A4 (en) | PREPARATION FOR PREVENTING OR REDUCING WRINKLES FOR ORAL INJECTION, FOR INJECTION OR FOR EXTERNAL APPLICATION TO THE SKIN AND COSMETIC PROCEDURE | |
MY165086A (en) | Formulations of rifaximin and uses thereof | |
MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
MX2018004616A (es) | Cosmetica qie tiene bacterias probioticas. | |
MX339842B (es) | Composiciones estimuladoras de paxilina y usos cosmeticos de las mismas. | |
HUP0800434A2 (en) | Template to determine the places of the injections, especially for regular medicament injection and/or blood testing | |
MX347848B (es) | Uso cosmético de las sulfoniloxibencilaminas n-sustituidas y compuestos relacionados. | |
WO2010104301A3 (en) | Cosmetic composition for skin moisturizing | |
WO2012012497A3 (en) | Non-tacky, film-forming water-in-oil cosmetic emulsion | |
MX337850B (es) | Lipoatrofia cosmetica medicinal. | |
MX2016000220A (es) | Regulacion del metabolismo de glucosa usando anticuerpos anti-cgrp. | |
MX2018007871A (es) | Composiciones para el cuidado personal. | |
CL2012002781A1 (es) | Producto que comprende un cuerpo de alimento compuesto por un componente de alimento y un componente de infusion que contiene mal todextrina en una concentracon de 5 a 65% con respecto al cuerpo del alimento; producto alimenticio; metodo para producir un cuerpo de alimento infusionado; y formulaciones de infusion. | |
WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
UA105940C2 (uk) | Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю | |
WO2014023649A3 (en) | Dermal cosmetic compositions having osmoprotecting activity | |
WO2011113785A3 (en) | A cosmetic composition for rejuvenating skin appearance | |
WO2011028797A3 (en) | Treatment of glaucoma and other retinopathies with gangliosides | |
PL2066409T3 (pl) | Zastosowanie ekstraktu z quinoa jako kosmetycznego i farmaceutycznego środka czynnego odchudzającego i/lub jako środka czynnego zapobiegającego tworzeniu się nowych tłuszczów w ludzkim ciele | |
UA29724U (ru) | Способ местного лечения острого глубокого кариеса зубов у детей и подростков |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |